Gregory Alan Korbel - Sep 10, 2021 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Chief Business Officer
Signature
/s/ Scott M. Coiante, attorney-in-fact
Stock symbol
APRE
Transactions as of
Sep 10, 2021
Transactions value $
-$7,913
Form type
4
Date filed
9/14/2021, 05:01 PM
Previous filing
Aug 27, 2021
Next filing
Sep 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability -$7.91K -1.72K -7.08% $4.59 22.6K Sep 10, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 5,000 restricted stock units.